Vivimed Labs Limited (VIVIMEDLAB) Stock Statistics & Valuation Metrics

Vivimed Labs Limited has a market cap or net worth of ₹428.66M. The enterprise value is ₹4.24K.

Vivimed Labs Limited has 82,913,910 shares outstanding. The number of shares has decreased by -2.65% in one year.

Vivimed Labs Limited’s return on equity (ROE) is 0.84 and return on invested capital (ROIC) is -28.28%.

The current PE Ratio of Vivimed Labs Limited is ―. Vivimed Labs Limited’s PEG ratio is -0.00058.

In the last 12 months, Vivimed Labs Limited had revenue of 699.89M and earned -1.76B in profits. Earnings per share was -21.15.

In the last 12 months, operating cash flow was 77.03M and capital expenditures -9.47M, giving a free cash flow of 67.56M billion.

Vivimed Labs Limited pays an annual dividend of ₹0.4, resulting in a dividend yield of ―

Vivimed Labs Limited upcoming earnings date is Nov 12, 2026, TBA (Confirmed).

Vivimed Labs Limited as a current ratio of 0.37, with Debt / Equity ratio of -188.70%

In the past 12 months, Vivimed Labs Limited has paid 1.38M in taxes.

Vivimed Labs Limited EV to EBITDA ratio is -3.03, with an EV/FCF ratio of 65.43.

Vivimed Labs Limited has ₹13.56M in cash and marketable securities with ₹3.97B in debt, giving a net cash position of -₹3.96B billion.

Gross margin is -78.26%, with operating margin of -255.02%, and net profit margin of -252.14%.

The average price target for Vivimed Labs Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―